Biogen Inc. (FRA:IDP)
Germany · Delayed Price · Currency is EUR 143.40
-2.60 (-1.78%)
At close: Dec 19, 2025
Biogen Employees
Biogen had 7,605 employees as of December 31, 2024. The number of employees increased by 35 or 0.46% compared to the previous year.
Employees
7,605
Change (1Y)
35
Growth (1Y)
0.46%
Revenue / Employee
€1,128,096
Profits / Employee
€180,266
Market Cap
21.88B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 7,605 | 35 | 0.46% |
| Dec 31, 2023 | 7,570 | -1,155 | -13.24% |
| Dec 31, 2022 | 8,725 | -885 | -9.21% |
| Dec 31, 2021 | 9,610 | 510 | 5.60% |
| Dec 31, 2020 | 9,100 | 1,700 | 22.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Deutsche Post AG | 573,964 |
| Siemens Aktiengesellschaft | 317,562 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 98,995 |
Biogen News
- 11 days ago - BIIB: Analyst Raises Price Target, Maintains Equal-Weight Rating | BIIB Stock News - GuruFocus
- 11 days ago - Biogen (BIIB) Downgraded by HSBC Amid Growth Concerns - GuruFocus
- 11 days ago - AbbVie upgraded, Biogen downgraded as HSBC reflects on 2026 in pharma - Seeking Alpha
- 11 days ago - This Biogen Analyst Turns Bearish; Here Are Top 4 Downgrades For Wednesday - Benzinga
- 11 days ago - HSBC Downgrades Biogen (BIIB) with New Target Price | BIIB Stock News - GuruFocus
- 12 days ago - Biogen Receives Health Canada Authorization for ZURZUVAE™ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in Canada - Business Wire
- 13 days ago - “LEQEMBI®” (lecanemab) for the Treatment of Early Alzheimer's Disease Included in China's Commercial Insurance Innovative Drug List - GlobeNewsWire
- 14 days ago - Eisai: New Data Presented at CTAD 2025 Confirms Pharmacological Effect of LEQEMBI(R) (lecanemab-irmb) on Neurotoxic Aβ Protofibrils in CSF - Finanz Nachrichten